Yoshihisa Kitamura Selected Research

Osteonecrosis (Kienbock's Disease)

1/2018	Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw.
1/2015	Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihisa Kitamura Research Topics

Disease

28	Parkinson Disease (Parkinson's Disease) 10/2021 - 03/2002
24	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 04/2002
14	Neoplasms (Cancer) 04/2022 - 01/2010
10	Treatment-Resistant Depressive Disorder 08/2020 - 01/2002
7	Cognitive Dysfunction 01/2021 - 10/2015
7	Amyloid Plaque 01/2012 - 04/2002
6	Brain Ischemia (Cerebral Ischemia) 01/2017 - 08/2007
5	Neuroblastoma 01/2018 - 11/2002
4	Hemorrhage 11/2022 - 01/2014
4	Neuroinflammatory Diseases 08/2022 - 11/2007
4	Inflammation (Inflammations) 01/2022 - 01/2019
4	Ischemia 11/2020 - 02/2003
4	Stroke (Strokes) 11/2020 - 07/2011
4	Breast Neoplasms (Breast Cancer) 03/2020 - 01/2015
3	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2017
3	Cerebral Hemorrhage 01/2022 - 09/2016
3	Dementia (Dementias) 10/2021 - 03/2016
3	Delirium 08/2021 - 01/2015
3	Hypothermia 01/2008 - 11/2003
2	Anemia 11/2022 - 01/2011
2	Tauopathies 04/2022 - 06/2007
2	Necrosis 03/2021 - 01/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 07/2020 - 01/2019
2	Constipation 01/2020 - 01/2018
2	Diarrhea 01/2020 - 01/2015
2	Pain (Aches) 01/2019 - 08/2018
2	Osteonecrosis (Kienbock's Disease) 01/2018 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2003
2	Hypertension (High Blood Pressure) 01/2015 - 11/2011
2	Insulin Resistance 11/2011 - 04/2010
2	Hyperinsulinism (Hyperinsulinemia) 11/2011 - 05/2008
2	Morphine Dependence 09/2011 - 03/2008
2	Opioid-Related Disorders (Opiate Addiction) 04/2011 - 03/2008
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2009 - 06/2008
2	Infarction (Infarctions) 01/2009 - 03/2008
2	Hyperglycemia 05/2008 - 12/2007
1	Hypoxia (Hypoxemia) 01/2023
1	Venous Thromboembolism 11/2022
1	Parkinsonian Disorders (Parkinsonism) 08/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2003
13	Neuroprotective AgentsIBA 01/2023 - 02/2003
11	Amyloid (Amyloid Fibrils)IBA 04/2022 - 03/2010
9	Dopamine (Intropin)FDA LinkGeneric 03/2015 - 03/2002
8	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2016 - 01/2002
8	Amyloid beta-PeptidesIBA 03/2010 - 04/2002
7	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2022 - 12/2008
6	RotenoneIBA 08/2022 - 11/2002
6	AntioxidantsIBA 01/2021 - 07/2011
6	Peptides (Polypeptides)IBA 01/2018 - 04/2002
5	Antidepressive Agents (Antidepressants)IBA 01/2017 - 06/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 10/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 07/2020 - 01/2019
4	Imipramine (Janimine)FDA LinkGeneric 11/2013 - 11/2003
3	UCP0054278IBA 01/2017 - 03/2009
3	Molecular Chaperones (Chaperone, Molecular)IBA 01/2017 - 03/2008
3	Pramipexole (Mirapex)FDA LinkGeneric 01/2014 - 07/2009
3	HMGB1 Protein (HMG1)IBA 01/2012 - 02/2003
2	LipidsIBA 04/2022 - 01/2015
2	Thrombin FDA Link 01/2022 - 08/2020
2	Arachidonic Acid (Vitamin F)IBA 01/2022 - 08/2020
2	LipopolysaccharidesIBA 01/2022 - 01/2019
2	CytokinesIBA 08/2020 - 06/2008
2	human ERBB2 proteinIBA 03/2020 - 01/2017
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2017
2	Magnesium Oxide (Magnesia)FDA Link 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2008
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2019 - 01/2015
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2018 - 12/2007
2	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2018 - 03/2013
2	Zoledronic Acid (Zometa)FDA Link 01/2018 - 01/2015
2	Denosumab FDA Link 01/2018 - 01/2015
2	Nicotine FDA Link 04/2017 - 04/2011
2	Nerve Growth Factor (NGF)IBA 01/2017 - 01/2010
2	Protein Deglycase DJ-1IBA 01/2017 - 01/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2015 - 04/2007
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2015 - 06/2003
2	O(4)-methylthymidine monophosphateIBA 01/2015 - 01/2013
2	Bupropion (Wellbutrin)FDA LinkGeneric 01/2014 - 08/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2012 - 03/2008
2	Levodopa (L Dopa)FDA LinkGeneric 01/2012 - 03/2002
2	FructoseIBA 11/2011 - 04/2010
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2010 - 05/2008
2	Insulin (Novolin)FDA Link 04/2010 - 05/2008
2	triphenyltetrazoliumIBA 01/2009 - 03/2008
2	Carbamazepine (Tegretol)FDA LinkGeneric 05/2008 - 04/2008
2	Serotonin (5 Hydroxytryptamine)IBA 12/2007 - 06/2002
1	roxadustatIBA 01/2023
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2023
1	alpha-SynucleinIBA 01/2023
1	edoxabanIBA 11/2022
1	Choline (Choline Chloride)IBA 04/2022

Therapy/Procedure

8	Therapeutics 11/2019 - 03/2002
7	Drug Therapy (Chemotherapy) 04/2022 - 10/2015
3	Transplantation 01/2020 - 10/2006
3	Aftercare (After-Treatment) 08/2018 - 12/2009
2	Terminal Care (Care, Terminal) 12/2019 - 01/2017
2	Kampo Medicine (Kampo) 01/2018 - 03/2010
1	Orthopedic Procedures 11/2022
1	Arthroplasty 11/2022